Functional and histochemical analysis on pancreatic islets of APA hamsters with SZ-induced hyperglycemia and hyperlipidemia

Experimental Animals

Volumn 51, Issue 1, 2002, Pages 9-17

  Takatori, Atsushi ^a   Nishida, Etsuko ^a   Inenaga, Toshiaki ^a   Horiuchi, Keiko ^a   Kawamura, Seiji ^a   Itagaki, Shin Ichi ^a   Yoshikawa, Yasuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

APA hamsters; Diabetes mellitus; Histochemistry; Pancreatic islet; Streptozotocin

Indexed keywords

CRICETINAE; MESOCRICETUS AURATUS;

CYCLINE; GLUCAGON; INSULIN; SOMATOSTATIN; STREPTOZOCIN;

ANIMAL; ARTICLE; CELL VACUOLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HAMSTER; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NICK END LABELING; PANCREAS ISLET; PATHOLOGY; SYRIAN HAMSTER;

ANIMALS; BLOOD GLUCOSE; CRICETINAE; DISEASE MODELS, ANIMAL; GLUCAGON; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INSULIN; ISLETS OF LANGERHANS; MALE; MESOCRICETUS; PROLIFERATING CELL NUCLEAR ANTIGEN; SOMATOSTATIN; STREPTOZOCIN; VACUOLES;

EID: 0036371029     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.51.9     Document Type: Article

References (26)

1. Anderson, W.A.D. 1977. Pancreas and diabetes mellitus. pp. 1472-1473. In: Pathology 7th Ed., the C. V. Mosby Company, St. Louis.
2. Arbeeny, C.M., Meyers, D.S., Bergquist, K.E., and Gregg, R.E. 1992. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J. Lipid Res. 33: 843-851.
3. Arison, R.N., Ciaccio, E.I., Glitzer, M.S., Cassaro, J.A., and Pruss, M.P. 1967. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16: 51-56.
4. Baetens, D., Stefan, Y., Ravazzola, M., Malaisse-Lagae, F., Coleman, D.L., and Orci, L. 1978. Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 27: 1-7.
5. Brosky, G. and Logothetopoulos, J. 1969. Streptozotocin diabetes in the mouse and guinea pig. Diabetes 18: 606-611.
6. Ebara, T., Hirano, T., Mamo, J.C., Sakamaki, R., Furukawa, S., Nagano, S., and Takahashi, T. 1994. Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison to streptozocin-diabetic rats. Metabolism 43: 299-305.
7. Han, J.S. and Doi, K. 1992. Morphometric study on the renal glomeruli of streptozotocin (SZ)-induced diabetic APA hamsters. Histol. Histopathol. 7: 549-554.
8. Han, J.-S., Norimatsu, M., Sugawara, Y., Doi, K., Shimura, K., Akai, H., Aikawa, T., and Tamura, K. 1990. Acute toxicity of streptozotocin in Syrian hamsters of the APA strain. J. Toxicol. Pathol. 3: 189-199.
9. Ma, P.T.S., Gil, G., Sudhof, T.C., Bilheimer, D.W., Goldstein, J.L., and Brown, M.S. 1986. Mevinolin, an inhibitor of cholesteryl synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc. Natl. Acad. Sci. 83: 8370-8374.
10. Nishida, E., Yamanouchi, J., Ogata, S., Doi, K., and Itagaki, S. 1997. Modification of spontaneous renal lesion of APA hamsters by streptozotocin-induced diabetes. Int. J. Exp. Pathol. 78: 169-176.
11. Phares, C.K. 1980. Streptozotocin-induced diabetes in Syrian hamsters: new model of diabetes mellitus. Experientia 36: 681-682.
12. Pitkin, R.M. and Reynolds, W.A. 1970. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 19: 85-90.
13. Pour, P.M., Duckworth, W., Carlson, K., and Kazakoff, K. 1990. Insulin therapy prevents spontaneous recovery from streptozotocin- induced diabetes in Syrian hamsters. An autoradiographic and immunohistochemical study. Virchows Arch. A Pathol. Anat. Histopathol. 417: 333-341.
14. Quig, D.W., Arbeeny, C.M., and Zilversmit, D.B. 1991. Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim Biophys Acta 1083: 257-264.
15. Rakieten, N., Gordon, B.S., Beaty, A., Cooney, D.A., Schein, P.S., and Dixon, R.L. 1976. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: Spontaneous reversibility of streptozotocin diabetes. Proc. Soc. Exp. Biol. Med. 151: 356-361.
16. Rosenberg, L., Duguid, W.P., Brown, R.A., and Vinik, A.I. 1988. Induction of nesidioblastosis will reverse diabetes in Syrian golden hamster. Diabetes 37: 334-341.
17. Rosenberg, L., Vinik, A.I., Pittenger, G.L., Rafaeloff, R., and Duguid, W.P. 1996. Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycaemia can be induced by a local growth factor(s). Diabetologia 39: 256-262.
18. Uchigata, Y., Yamamoto, H., Kawamura, A., and Okamoto, H. 1982. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 257: 6084-6088.
19. Uchigata, Y., Yamamoto, H., Nagai, H., and Okamoto, H. 1983. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32: 316-318.
20. Veleminsky, J., Burr, I.M., and Stauffacher, W. 1970. Comparative study of early metabolic events resulting from the administration of the two diabetogenic agents alloxan and streptozotocin. Eur. J. Clin. Invest. 1: 104-108.
21. Waguri, M., Yamamoto, K., Miyagawa, J.I., Tochino, Y., Yamamori, K., Kajimoto, Y., Nakajima, H., Watada, H., Yoshiuchi, I., Itoh, N., Imagawa, A., Namba, M., Kuwajima, M., Yamasaki, Y., Hanafusa, T., and Matsuzawa, Y. 1997. Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. Diabetes 46: 1281-1290.
22. Wilander, E. and Boquist, L. 1972. Streptozotocin-diabetes in the Chinese hamster. Blood glucose and structural changes during the first 24 hours. Horm. Metab. Res. 4: 426-433.
23. Yamamoto, K., Miyagawa, J., Waguri, M., Sasada, R., Igarashi, K., Li, M., Nammo, T., Moriwaki, M., Imagawa, A., Yamagata, K., Nakajima, H., Namba, M., Tochino, Y., Hanafusa, T., and Matsuzawa, Y. 2000. Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 49: 2021-2027.
24. Yamanouchi, J., Sugawara, Y., Itagaki, S., and Doi, K. 1997. Ultrastructure of atheromatous lesions experimentally induced in Syrian hamsters of the APA strain. Histol. Histopathol. 12: 433-438.
25. Yamanouchi, J., Nishida, E., Itagaki, S., Kawamura, S., Doi, K., and Yoshikawa, Y. 2000. Aortic atheromatous lesions developed in APA hamsters with streptozotocin induced diabetes: a new animal model for diabetic atherosclerosis. I. Histopathological studies. Exp. Anim. 49: 259-266.
26. Yamanouchi, J., Takatori, A., Itagaki, S., Kawamura, S., and Yoshikawa, Y. 2000. APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins. Exp. Anim. 49: 267-274.